Marc LeBel joins Nuchem Therapeutics as President July 2017

Nuchem Therapeutics is pleased to announce that Marc LeBel, a highly respected entrepreneur in Québec, has joined our company as President.

Founding president and CEO of Anapharm Inc, and following its acquisition, executive vice-president of Pharmanet Inc., Marc brings his vast experience from the CRO world to Nuchem Therapeutics. He has received the Excelsia 2006 award from BioQuébec which recognizes his remarkable personal contribution to the advancement of the life sciences industry as well as the leadership prize from the Canadian Society of Pharmaceutical Sciences and the Prix des Grands Diplômés from Université Laval.